Return to search results
Oxybutynin chloride
Oxybutynin Chloride is a prescription medication used to treat overactive bladder symptoms like frequent urination and incontinence. It comes as extended-release oral tablets in 5mg, 10mg, and 15mg strengths, manufactured by Accord Healthcare under ANDA207138. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Oxybutynin Chloride is a prescription medication used to treat overactive bladder symptoms like frequent urination and incontinence. It comes as extended-release oral tablets in 5mg, 10mg, and 15mg strengths, manufactured by Accord Healthcare under ANDA207138. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Oxybutynin chloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Oxybutynin chloride — ANDA 214415 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214415"
}
]
|
| identifier | ANDA214415 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"fda",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Oxybutynin chloride |
